Scientists test One-Shot gene therapy to fight deadly brain cancer
NCT ID NCT03866109
Summary
This early-stage study is testing the safety of a new, one-time gene therapy called Temferon for patients with a specific, hard-to-treat form of glioblastoma brain cancer. Doctors take a patient's own blood stem cells, genetically modify them to produce a cancer-fighting protein, and then return them to the patient. The main goal is to see if this treatment is safe and what dose might work best for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
Milan, 20133, Italy
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Policlinico Universitario Fondazione Agostino Gemelli
Rome, Italy
Conditions
Explore the condition pages connected to this study.